Cargando…
Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this si...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356968/ https://www.ncbi.nlm.nih.gov/pubmed/22629102 http://dx.doi.org/10.4103/0976-500X.95534 |